Market Place
Sourcing Support
All News #Library
Others
Gan & Lee Licenses Bofanglutide Globally to JW Pharma
09 Apr 2026 //
PR NEWSWIRE
Lupin and Gan & Lee Pharma Enter Exclusive Licensing Deal
29 Dec 2025 //
INDPHARMAPOST
Gan & Lee Pharmaceuticals` Diabetes Therapies at ADA
22 Jun 2025 //
PR NEWSWIRE
Implantica Opens Two New RefluxStop™ Centers in Spain
18 Dec 2024 //
PR NEWSWIRE
Gan & Lee Presents Phase 2b Data for GZR18 in Obese Adults
11 Nov 2024 //
PR NEWSWIRE
Gan & Lee Presents GZR4 Insulin Results At EASD 2024
14 Sep 2024 //
PR NEWSWIRE
Gan & Lee To Present Data On Innovative Products At ADA
17 Jun 2024 //
PR NEWSWIRE
Gan & Lee Pharmaceuticals Begins First-In-Human Trial in U.S. for GZR18
10 Mar 2022 //
PRNEWSWIRE
Gan & Lee Pharmaceuticals Concludes Phase 3 Studies of Gan & Lee
16 Oct 2021 //
INDIANWEB2
Gan & Lee to present data at the 57th Annual EASD 2021
08 Sep 2021 //
PRNASIA
New Data on Phase 1 Proposed Biosimilar Gan & Lee Insulins Aspart (GL-ASP)
02 Jul 2021 //
PR NEWSWIRE
New data on the insulins Aspart (GL-ASP), Lispro (GL-LIS) and Glargine (GL-GLA)
02 Jul 2021 //
PR NEWSWIRE
Phase 1 Drug Candidate GLR2007 has been Granted Orphan Drug Designation
11 Sep 2020 //
PRNNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.